Genprex, Inc. Files 8-K with Presentation Materials
Ticker: GNPX · Form: 8-K · Filed: Apr 21, 2026 · CIK: 0001595248
Sentiment: neutral
Topics: regulation-fd, presentation, filing-update
Related Tickers: GNPX
TL;DR
Genprex dropped an 8-K with presentation slides on 4/21, check it out.
AI Summary
On April 21, 2026, Genprex, Inc. filed an 8-K report detailing events from March 29, 2026. The filing includes information under Regulation FD Disclosure and Other Events, along with financial statements and exhibits. The report primarily consists of various graphic files, suggesting a presentation or visual update was shared.
Why It Matters
This filing indicates Genprex, Inc. has released new information or updates, potentially related to its business or financial status, through a presentation format.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediate indication of significant negative events or financial distress.
Key Players & Entities
- Genprex, Inc. (company) — Filer of the 8-K report
- 0001595248 (company) — CUSIP number for Genprex, Inc.
- 0001437749-26-012879 (filing_id) — SEC Accession Number for the 8-K filing
- 2026-04-21 (date) — Filing Date and Period of Report
- 2026-03-29 (date) — Date referenced in the filing document name
FAQ
What specific information was disclosed under Regulation FD?
The filing does not explicitly detail the content of the Regulation FD disclosure, but it is presented alongside other events and exhibits.
What is the primary nature of the documents attached to this 8-K filing?
The majority of the attached documents are graphic files (JPGs), suggesting a presentation or visual update was included.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 21, 2026, at 07:02:55.
What period does this 8-K report cover?
The period of report is April 21, 2026.
Are there any specific financial statements included in this filing?
The filing lists 'Financial Statements and Exhibits' under Item 9.01, and Exhibit 99.1 is included, though the specific content of financial statements is not detailed in the provided metadata.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 21, 2026 regarding Genprex, Inc. (GNPX).